Improve Your Commercial Growth Strategy with Custom-Tailored Intelligence

LEARN MORE

Doing it Right, part 3

by

Here is a story about a remarkable young man who developed his own cancer diagnostic test. Interesting to note that the target chosen by this young man, mesothelin, has known diagnostic and prognostic indications, and yet there is not an FDA-cleared or approved IVD on the market. Innovation can come from anywhere today.

Cancer, Innovation and a Boy Named Jack – Forbes.

PageLines